ABVX
Price
$88.10
Change
+$2.55 (+2.98%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
6.41B
2 days until earnings call
XENE
Price
$39.23
Change
+$0.60 (+1.55%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
3.02B
60 days until earnings call
Interact to see
Advertisement

ABVX vs XENE

Header iconABVX vs XENE Comparison
Open Charts ABVX vs XENEBanner chart's image
Abivax SA
Price$88.10
Change+$2.55 (+2.98%)
Volume$38.61K
Capitalization6.41B
Xenon Pharmaceuticals
Price$39.23
Change+$0.60 (+1.55%)
Volume$14.4K
Capitalization3.02B
ABVX vs XENE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. XENE commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and XENE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ABVX: $85.55 vs. XENE: $38.64)
Brand notoriety: ABVX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 45% vs. XENE: 86%
Market capitalization -- ABVX: $6.41B vs. XENE: $3.02B
ABVX [@Biotechnology] is valued at $6.41B. XENE’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • XENE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XENE is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +4.79% price change this week, while XENE (@Biotechnology) price change was +0.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

XENE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($6.42B) has a higher market cap than XENE($3.02B). ABVX YTD gains are higher at: 1068.716 vs. XENE (-1.429). ABVX has higher annual earnings (EBITDA): -170.04M vs. XENE (-315.5M). XENE has more cash in the bank: 488M vs. ABVX (104M). XENE has less debt than ABVX: XENE (8.72M) vs ABVX (92.6M). XENE has higher revenues than ABVX: XENE (7.5M) vs ABVX (0).
ABVXXENEABVX / XENE
Capitalization6.42B3.02B212%
EBITDA-170.04M-315.5M54%
Gain YTD1068.716-1.429-74,810%
P/E RatioN/AN/A-
Revenue07.5M-
Total Cash104M488M21%
Total Debt92.6M8.72M1,063%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXXENE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVDX16.500.29
+1.79%
Janus Henderson Small-Mid Cap Value D
PGSGX18.130.24
+1.34%
JPMorgan Small Cap Growth A
LADIX25.000.15
+0.60%
ClearBridge Tactical Dividend Income I
GGOCX22.200.13
+0.59%
Goldman Sachs Mid Cap Growth C
RGBLX40.420.16
+0.40%
American Funds Global Balanced R1

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+2.27%
IMNN - ABVX
57%
Loosely correlated
-0.17%
CLSD - ABVX
51%
Loosely correlated
+3.00%
ANEB - ABVX
46%
Loosely correlated
-2.85%
MLTX - ABVX
38%
Loosely correlated
+0.37%
XENE - ABVX
38%
Loosely correlated
-0.49%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-0.49%
IDYA - XENE
58%
Loosely correlated
+0.27%
CRNX - XENE
55%
Loosely correlated
-1.15%
NRIX - XENE
52%
Loosely correlated
-3.59%
ADVM - XENE
51%
Loosely correlated
-2.46%
ATXS - XENE
51%
Loosely correlated
+0.14%
More